Healio
Healio

Glaucoma 360 New Horizons Forum
ByMalik Y. Kahook, MD
ByEamon N. Dreisbach
Fact checked byChristine Klimanskis, ELS

Read more

February 16, 2023
2 min watch
Save

VIDEO: Bimatoprost drug delivery platform offers encouraging 6-month results

ByMalik Y. Kahook, MD
ByEamon N. Dreisbach
Fact checked byChristine Klimanskis, ELS
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Malik Y. Kahook, MD, discusses study data investigating the Spyglass drug delivery platform, which offers sustained delivery of bimatoprost.

Kahook presented 6-month data investigating use of the hydrophobic acrylic IOL and drug-eluting pads.

“We show a mean reduction in intraocular pressure of 45%, and just as noteworthy is the fact that all of the eyes remain off of topical therapy,” he said. “We are very excited about the results to date and will continue to follow and share the data along the way.”

Sources/Disclosures

Collapse
Source:

Kahook MY. Sustained drug delivery for glaucoma: From promise to reality. Presented at: Glaucoma 360 New Horizons Forum; Feb. 3, 2023; San Francisco.

Disclosures: Kahook reports being the founder and executive chair of the board for Spyglass Pharma.

Read more about

glaucoma
drug delivery system
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

 

Related Content